PCN100 Cemiplimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma in Italy: A Budget Impact Analysis
Abstract
Authors
G. Ghetti M.C. D'Avella L. Pradelli
G. Ghetti M.C. D'Avella L. Pradelli
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now